drugset / Trial / NCT00607789

Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression

NCT00607789

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to test the safety of duloxetine and see what effects (good and bad) it has on the subject's binge eating disorder and comorbid depressive disorder (depression occurring with binge eating disorder) compared to placebo (inactive pill).

Timeline

Start
2006-10
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg
Subject Duloxetine Small molecule 120 mg